Read the latest from RareKids-CAN.
RareKids-CAN’s Clinical Trial Navigators help strengthen pediatric rare disease clinical trial capacity across Canada by serving as a local contact…
RareKids-CAN’s Clinical Trial Navigator network supports pediatric rare disease clinical trial readiness across Canada by helping connect institutions, investigators, and…
RareKids-CAN, Canada’s pediatric rare disease clinical trials and treatment network funded by the Canadian Institutes for Health Research, supports Bill…
Patients and families are central to RareKids-CAN and our work. As part of our commitment to Strategic Priority 1: Enhancing…
Progress in rare disease research rarely comes from a single breakthrough, it’s built through persistence, curiosity, and a commitment to…
For many children living with rare conditions, the biggest challenges aren’t always the ones you see on a chart; they…
RareKids-CAN Nominated Principal Investigator, Thierry Lacaze, presents at the March 2026 ERDERA Meeting. The Canadian National Mirror Group (NMG) continues…
Genevieve Currie (left) and Leah Sarah Peer (right) have joined the Global Rare Disease Priority Setting Partnership Steering Commitee at…
On February 28th, the RareKids-CAN community came together in a powerful show of collaboration and progress to celebrate Rare Disease Day…
